News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,358 Results
Type
Article (49245)
Company Profile (316)
Press Release (675797)
Section
Business (212051)
Career Advice (2087)
Deals (36490)
Drug Delivery (98)
Drug Development (83426)
Employer Resources (169)
FDA (16899)
Job Trends (15671)
News (358758)
Policy (34610)
Tag
Academia (2758)
Alliances (51360)
Alzheimer's disease (1309)
Approvals (16846)
Artificial intelligence (160)
Bankruptcy (364)
Best Places to Work (12040)
Biotechnology (218)
Breast cancer (194)
Cancer (1405)
Cardiovascular disease (117)
Career advice (1750)
Cell therapy (286)
Clinical research (66599)
Collaboration (496)
Compensation (261)
COVID-19 (2667)
C-suite (115)
Data (1408)
Diabetes (178)
Diagnostics (6382)
Earnings (87010)
Employer resources (147)
Events (114961)
Executive appointments (403)
FDA (17590)
Funding (438)
Gene therapy (199)
GLP-1 (647)
Government (4603)
Healthcare (19775)
Infectious disease (2762)
Inflammatory bowel disease (116)
Interviews (317)
IPO (16705)
Job creations (4040)
Job search strategy (1497)
Layoffs (436)
Legal (8415)
Lung cancer (205)
Lymphoma (99)
Manufacturing (212)
Medical device (14209)
Medtech (14214)
Mergers & acquisitions (19942)
Metabolic disorders (484)
Neuroscience (1645)
NextGen Class of 2024 (6900)
Non-profit (4727)
Northern California (1707)
Obesity (280)
Opinion (197)
Patents (118)
People (59294)
Phase I (20693)
Phase II (29268)
Phase III (21874)
Pipeline (517)
Postmarket research (2738)
Preclinical (8831)
Radiopharmaceuticals (246)
Rare diseases (265)
Real estate (6287)
Regulatory (23072)
Research institute (2472)
Resumes & cover letters (359)
Southern California (1474)
Startups (3817)
United States (15515)
Vaccines (601)
Weight loss (207)
Date
Today (3)
Last 7 days (603)
Last 30 days (2395)
Last 365 days (36072)
2024 (35894)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55915)
2019 (48798)
2018 (36939)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (789)
Arizona (203)
Asia (40418)
Australia (6659)
California (3852)
Canada (1456)
China (311)
Colorado (179)
Connecticut (189)
Europe (87424)
Florida (537)
Georgia (143)
Illinois (415)
Indiana (229)
Maryland (655)
Massachusetts (3025)
Michigan (177)
Minnesota (301)
New Jersey (1120)
New York (1094)
North Carolina (801)
Northern California (1707)
Ohio (147)
Pennsylvania (929)
South America (1180)
Southern California (1474)
Texas (560)
Utah (111)
Washington State (410)
725,358 Results for "oncosec medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
OncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical program
OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec) today announced a Type C meeting held with the US Food and Drug Administration (FDA) on May 15, 2023.
May 16, 2023
·
8 min read
Press Releases
BRIJ Medical, Inc. Awarded Breakthrough Technology Agreement in the Non-Invasive Skin Closure Category with Premier, Inc.
December 17, 2024
·
2 min read
Business
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
July 1, 2024
·
2 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Business
GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.
June 20, 2024
·
2 min read
Biotech Beach
OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
OncoSec Medical Incorporated announced the closing of its previously announced registered direct offering of 1,408,384 shares of its common stock, at a purchase price of $0.945 per share, priced at-the-market under Nasdaq rules.
May 18, 2023
·
7 min read
Press Releases
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
November 12, 2024
·
1 min read
Deals
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.
June 18, 2024
·
7 min read
Press Releases
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024
November 11, 2024
·
1 min read
Drug Development
OncoSec Announces Clinical Data of the KEYNOTE-695 Trial Assessing TAVO™-EP in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatment
OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient’s immune system to target cancer cells and eradicate disease, today announced primary endpoint data from the Phase 2 KEYNOTE-695 clinical trial.
April 3, 2023
·
8 min read
1 of 72,536
Next
